75.31
-2.89
(-3.70%)
At close: 4:00:02 PM EDT
75.31
0.00
(0.00%)
After hours: 5:05:00 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 6 |
Avg. Estimate | 0.18 | 1.13 | 3.68 | 4.66 |
Low Estimate | 0.13 | 1.05 | 3.35 | 4.18 |
High Estimate | 0.29 | 1.21 | 3.87 | 4.93 |
Year Ago EPS | 0.73 | 0.91 | 3.02 | 3.68 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | 614.5M | 764.5M | 2.89B | 3.08B |
Low Estimate | 598M | 753.4M | 2.83B | 3.02B |
High Estimate | 624.2M | 770M | 2.93B | 3.18B |
Year Ago Sales | 598.6M | 664.7M | 2.57B | 2.89B |
Sales Growth (year/est) | 2.66% | 15.01% | 12.44% | 6.58% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 0.52 | 0.83 | 0.85 | 0.76 |
EPS Actual | 0.73 | 0.91 | 0.91 | 0.46 |
Difference | 0.21 | 0.08 | 0.06 | -0.3 |
Surprise % | 39.85% | 9.38% | 7.31% | -39.73% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.18 | 1.13 | 3.68 | 4.66 |
7 Days Ago | 0.2 | 1.13 | 3.7 | 4.68 |
30 Days Ago | 0.45 | 1.21 | 4.14 | 5.08 |
60 Days Ago | 0.54 | 1.37 | 4.34 | 5.34 |
90 Days Ago | 0.53 | 1.37 | 4.42 | 5.36 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | 1 | -- | -- |
Up Last 30 Days | -- | 1 | -- | -- |
Down Last 7 Days | 3 | 2 | 4 | 3 |
Down Last 30 Days | 5 | 4 | 6 | 5 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ACA | -74.75% | 24.16% | 21.84% | 26.75% |
S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
Maintains | Oppenheimer: Outperform to Outperform | 1/14/2025 |
Initiated | Barclays: Overweight | 10/29/2024 |
Maintains | Oppenheimer: Outperform to Outperform | 8/19/2024 |
Upgrade | Stephens & Co.: Equal-Weight to Overweight | 8/7/2024 |
Maintains | DA Davidson: Buy to Buy | 5/17/2024 |
Maintains | DA Davidson: Buy to Buy | 5/6/2024 |
Related Tickers
ROAD Construction Partners, Inc.
78.11
-1.28%
ECG Everus Construction Group, Inc.
37.97
-4.07%
NVEE NV5 Global, Inc.
16.62
-3.03%
PRIM Primoris Services Corporation
56.42
-3.69%
MTRX Matrix Service Company
10.22
-6.24%
MTZ MasTec, Inc.
115.06
-5.57%
CDLR Cadeler A/S
19.40
+0.67%
ORN Orion Group Holdings, Inc.
5.53
-0.54%
VATE INNOVATE Corp.
5.88
-5.01%
EXPO Exponent, Inc.
79.00
-0.99%